Epigenetic agents, including DNMT inhibitors (DNMTIs) and histone deacetylase (HDAC) inhibitors, have provided tremendous promise for the treatment of advanced, metastatic cancer by episensitization to overcome chemotherapy resistance53,54. The gene discussed is DNMT1; the disease is metastatic malignant neoplasm.